JRSS (JRSIS Health Care) Cash-to-Debt: No Debt (1) (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is JRSIS Health Care Cash-to-Debt?

JRSIS Health Care JRSS Cash-to-Debt is No Debt (1) as of Mar. 2025.

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. JRSIS Health Care's cash to debt ratio for the quarter that ended in Mar. 2025 was No Debt (1).

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, JRSIS Health Care could pay off its debt using the cash in hand for the quarter that ended in Mar. 2025.

(1) Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

The historical rank and industry rank for JRSIS Health Care's Cash-to-Debt or its related term are showing as below:

JRSS's Cash-to-Debt is not ranked *
in the Retail - Cyclical industry.
Industry Median: 0.46
* Ranked among companies with meaningful Cash-to-Debt only.

JRSIS Health Care  (OTCPK:JRSS) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


JRSIS Health Care Cash-to-Debt Related Terms


JRSIS Health Care Cash-to-Debt Historical Data

* Premium members only.

The historical data trend for JRSIS Health Care's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

JRSIS Health Care Cash-to-Debt Chart

JRSIS Health Care Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash-to-Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.05 No Debt 0.10 7.87 No Debt

JRSIS Health Care Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.31 0.00 No Debt No Debt

JRSS vs NVVE, FTEL, QSJC: Cash-to-Debt Comparison

For the Specialty Retail subindustry, JRSIS Health Care's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JRSIS Health Care Cash-to-Debt vs Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, JRSIS Health Care's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where JRSIS Health Care's Cash-to-Debt falls into.



JRSIS Health Care Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

JRSIS Health Care's Cash to Debt Ratio for the fiscal year that ended in Dec. 2024 is calculated as:

JRSIS Health Care had no debt (1).

JRSIS Health Care's Cash to Debt Ratio for the quarter that ended in Mar. 2025 is calculated as:

JRSIS Health Care had no debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash-to-Debt →
What does a Cash-to-Debt of No Debt <sup>(1)</sup> mean?
JRSIS Health Care (JRSS) has a Cash-to-Debt of No Debt (1) as of Mar. 2025.
Is JRSIS Health Care's Cash-to-Debt too high?
JRSIS Health Care's current Cash-to-Debt is No Debt (1).
How does JRSIS Health Care's Cash-to-Debt compare to NVVE and FTEL?
JRSIS Health Care's Cash-to-Debt of No Debt (1) can be compared against companies in the Retail - Cyclical industry. The industry median Cash-to-Debt is 0.46. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Retail - Cyclical company?
The median Cash-to-Debt among Retail - Cyclical companies is 0.46, based on 1,121 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Retail - Cyclical industry, the median Cash-to-Debt is 0.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JRSIS Health Care's current Cash-to-Debt is No Debt (1). However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JRSIS Health Care stock overvalued right now?
JRSIS Health Care (JRSS) has a current Cash-to-Debt of No Debt (1). The current Cash-to-Debt is No Debt (1). Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For JRSIS Health Care (JRSS), the current Cash-to-Debt is No Debt (1) as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

JRSIS Health Care Business Description

Address Yongzhou Economic and Technology Development Zone, Building 2, Youth Innovation and Entrepreneurship Park, Xiaoxiang Science and Technology Innovation Center, Hunan Province, Yongzhou, CHN, 425000
JRSIS Health Care Corp, through its subsidiaries, is mainly engaged in providing charging services to electric vehicles incorporated in Zhongshan City of Guangdong, China.